Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK/Nrf2 signalling pathway

Doxorubicin (DOX), an anthracycline chemotherapy, plays a prominent role in the treatment of various cancers. Unfortunately, its nephrotoxic effects limit its dosing and expose cancer survivors to increased morbidity and mortality. This study examined the nephroprotective effects of eriodictyol, a n...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Rehab Mustafa Badi, Eman Farok Khaleel, Huda Hammed Satti, Rehan Monir
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2024-03-01
Cyfres:	Journal of Traditional and Complementary Medicine
Pynciau:	Eriodictyol Doxorubicin Nephroprotective Flavanone p-AMPK
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2225411023001177
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!